CGPVF yields 1.49% · PFE yields 6.13%● Live data
📍 PFE pulled ahead of the other in Year 9
Combined, CGPVF + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of CGPVF + PFE for your $10,000?
Viridien engages in the provision of data, products, services, and solutions in Earth science, data science, sensing, and monitoring in North America, Latin America, the Central and South Americas, Europe, Africa, the Middle East, and the Asia Pacific. It operates through two segments: Data, Digital & Energy Transition (DDE); and Sensing & Monitoring (SMO). The DDE segments engages in the developing and licensing Earth data seismic surveys; processing and imaging seismic data; sale of seismic data processing software under the Geovation brand; provision of geoscience and petroleum engineering consulting services; and collecting, developing, and licensing geological data. The SMO segment is involved in the design, engineering, and manufacturing of seismic equipment for the land and marine seismic data acquisition, including seismic recording equipment, software, and seismic sources for land vibrators or marine sources, and sensing and monitoring equipment and solutions under the Sercel, Metrolog, GRC, DeRegt, and Geocomp brand names. This segment also provides customer support services, such as training. It provides its solutions for natural resources, environmental, infrastructure, energy transition, and digital applications. The company was formerly known as CGG and changed its name to Viridien in May 2024. Viridien was incorporated in 1931 and is headquartered in Massy, France.
Full CGPVF Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.